Market Cap
$72.7B
CI
Cigna Group
$267.96 ▼ -1.42%
Prev close $271.83Market cap$72.7B
ConsensusBuy
12-mo target$341.04 (+27.3%)
▲ Bullish
Analyst conviction 8/10
Insider Selling Cluster (2 insiders)High Impact Filing (7/10)35 New Institutional Positions15 Institutional Exits Traditional Finance
Snapshot
The big-picture read on CI right now — valuation, ownership and activity at a glance.
Cap Size
Large Cap
Analyst Consensus
Strong Buy (76%)
Inst. Holders
50 funds
Inst. Value
$51.0B
Inst. Activity
35 buys / 15 sells
Insider Activity
$0.00 buy / $66.8M sell
Insider Net $
-$66.8M
Social Sentiment
11° Bearish
SEC Reports
10
Congressional
5 trades
Price chart 30d -5.3%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Sep 30, 2026 short_volume
Sep 3, 2026 SEC Short Volume: CI — 62.3% short (0.8M / 1.2M)
Short: 773,878 | Exempt: 26 | TRF Vol: 1,242,907 | Short Ratio: 62.3% | Off-exchange volume (dark po
Frank Neville, an officer of Cigna Group, filed a Form 144 notice of intent to sell 617 shares of common stock with an a
144 — Impact 2/10
Sep 3, 2026 Insider
Neville Everett sold 617 shares
See Remarks @ $284.05 ($175.3K)
Sep 1, 2026 Insider
Evanko Brian C was granted 6,716 shares
See Remarks
Sep 1, 2026 Insider
Aug 18, 2026 SEC Evanko Brian C was granted 3,113 shares
See Remarks
Nicole S. Jones, an officer of Cigna Group, filed a Form 144 on August 18, 2026, indicating intent to sell 2,677 shares
144 — Impact 2/10
Nicole S. Jones, an Officer of Cigna Group, filed a Form 144 notice of intent to sell 19,436 shares of common stock with
144 — Impact 2/10
Jun 30, 2026 Inst.
FMR LLC — TRIM
8,018,189 shares ($2.2B)
Analyst ratings buy % -7.3%
How Wall Street rates the stock today, and the latest firm-by-firm actions.
76% rate it Buy or better · 34 analysts
Recent analyst actions
| Date | Firm | Action | Rating | Firm rating |
|---|---|---|---|---|
| Oct 1, 2026 | RBC Capital | REITERATE | Outperform | 55% |
| Aug 4, 2026 | Jefferies | DOWNGRADE | Hold | 53% |
| Aug 3, 2026 | Raymond James | DOWNGRADE | Outperform | 54% |
| Jul 31, 2026 | Wells Fargo | MAINTAIN | Equal-Weight | 54% |
| Jul 31, 2026 | Guggenheim | MAINTAIN | Buy | 52% |
| Jul 31, 2026 | Barclays | MAINTAIN | Equal-Weight | 54% |
| Jul 9, 2026 | Bernstein | MAINTAIN | Outperform | 51% |
| Jun 8, 2026 | Mizuho | MAINTAIN | Outperform | 52% |
| May 26, 2026 | Barclays | DOWNGRADE | Equal-Weight | 54% |
| May 22, 2026 | UBS | MAINTAIN | Buy | 55% |
Monthly consensus history
| Period | Str. Buy | Buy | Hold | Sell | Str. Sell | Buy % | Distribution |
|---|---|---|---|---|---|---|---|
| Sep 1, 2026 | 9 | 17 | 8 | 0 | 0 | 76% | |
| Aug 1, 2026 | 11 | 16 | 7 | 0 | 0 | 79% | |
| Jul 1, 2026 | 11 | 17 | 5 | 0 | 0 | 85% | |
| Jun 1, 2026 | 11 | 17 | 5 | 0 | 0 | 85% | |
| May 1, 2026 | 11 | 18 | 5 | 0 | 0 | 85% | |
| Apr 1, 2026 | 11 | 18 | 5 | 0 | 0 | 85% | |
| Mar 1, 2026 | 10 | 17 | 6 | 0 | 0 | 82% | |
| Feb 1, 2026 | 10 | 17 | 6 | 0 | 0 | 82% |
Price targets
Where 24 covering analysts think CI trades over the next 12 months.
$341.04 +27.3% upside Strong Buy
Current$267.96 Low$288.00 Median$343.00 High$400.00 24 analysts
$288.00$400.00
Analyst rating Buy· 1.8/5 as of Oct 2, 2026
Social media sentiment mood +0.0%
Retail-investor mood aggregated across social media. 0° = very bearish, 100° = very bullish.
11°
Bearish
BearishNeutralBullish
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
10 SEC filing reports analyzed · 1 bullish, 0 bearish, 0 mixed, 9 neutral · avg impact 3.0/10.
NEUTRAL1442/10
Frank Neville, an officer of Cigna Group, filed a Form 144 notice of intent to sell 617 shares of co
Sep 3, 2026
NEUTRAL1442/10
Nicole S. Jones, an officer of Cigna Group, filed a Form 144 on August 18, 2026, indicating intent t
Aug 18, 2026
NEUTRAL1442/10
Nicole S. Jones, an Officer of Cigna Group, filed a Form 144 notice of intent to sell 19,436 shares
Aug 4, 2026
NEUTRAL32/10
Jason Sadler, newly appointed President of Cigna Healthcare International Health, filed a Form 3 ini
Jul 10, 2026
Upcoming & catalyst events
Scheduled dates plus disclosed catalysts — earnings, dividends, enforcement, FDA and clinical-trial events. Colored dot = impact.
Sep 30, 2026
short_volume
Short Volume: CI — 62.3% short (0.8M / 1.2M)
Short: 773,878 | Exempt: 26 | TRF Vol: 1,242,907 | Short Ratio: 62.3% | Off-exchange volume (dark pool + OTC)
Sep 10, 2026
short_volume
Short Volume: CI — 62.7% short (0.4M / 0.6M)
Short: 368,584 | Exempt: 2 | TRF Vol: 587,771 | Short Ratio: 62.7% | Off-exchange volume (dark pool + OTC)
Sep 9, 2026
routine
The Cigna Group to Host Investor Day on September 30
BLOOMFIELD, Conn., Sept. 9, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE: CI) will host its Investor Day on Wednesday, September 3
Sep 7, 2026
dark_pool
Dark Pool: CI — 1.6M shares, 59,680 trades
Week starting 2026-09-07. Total ATS volume: 1,631,878 shares across 59,680 trades.
Aug 31, 2026
dark_pool
Dark Pool: CI — 1.4M shares, 56,477 trades
Week starting 2026-08-31. Total ATS volume: 1,422,542 shares across 56,477 trades.
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $7.50 | $7.42–$7.68 | -4.2% | +0.1% | 5↑ 16↓ | $72.5B | 22 |
| Next Q | $7.42 | $7.22–$7.63 | -8.1% | -0.0% | 15↑ 6↓ | $74.6B | 22 |
| Current FY | $30.51 | $30.44–$30.71 | 2.2% | +0.0% | 19↑ 2↓ | $287.5B | 24 |
| Next FY | $33.43 | $32.76–$33.84 | 9.6% | -0.2% | 17↑ 3↓ | $298.9B | 24 |
Current-quarter EPS estimate — revision history
| When | EPS estimate | Change vs now |
|---|---|---|
| Current | $7.499 | — |
| 7d ago | $7.495 | +0.004 |
| 30d ago | $7.494 | +0.004 |
| 60d ago | $7.578 | -0.079 |
| 90d ago | $7.617 | -0.118 |
Institutional ownership
Which big funds own CI (from quarterly 13F filings) and who is adding or trimming.
50 institutional holders with $51.0B total value (184,844,736 shares) as of 2026-Q2. Top holders: BlackRock,, VANGUARD, STATE. Net buying activity: 35 institutions added/increased vs 15 reduced.
Top holders — 2026-Q2
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| BlackRock, Inc. | 23,438,250 | $6.5B | 12.7% | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 17,276,296 | $4.8B | 9.3% | — |
| STATE STREET CORP | 12,682,259 | $3.5B | 6.9% | — |
| DODGE & COX | 12,173,875 | $3.4B | 6.6% | — |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 10,443,691 | $2.9B | 5.7% | — |
| Sanders Capital, LLC | 10,144,617 | $2.8B | 5.5% | — |
| FMR LLC | 8,018,189 | $2.2B | 4.3% | TRIM -26.8% |
| GEODE CAPITAL MANAGEMENT, LLC | 6,268,347 | $1.7B | 3.4% | — |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 6,228,614 | $1.7B | 3.4% | — |
| GQG Partners LLC | 5,908,707 | $1.6B | 3.2% | — |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| FMR LLC | TRIM | 10,957,272 | 8,018,189 | -26.8% | $2.2B |
| NORGES BANK | NEW | — | 3,562,699 | — | $982.2M |
| HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC | DOUBLED | 497,105 | 2,024,152 | +307.2% | $558.0M |
| NATIONAL BANK OF CANADA /FI/ | DOUBLED | 196,328 | 1,436,453 | +631.7% | $396.0M |
| Nuveen, LLC | TRIM | 1,847,126 | 1,349,647 | -26.9% | $372.1M |
| Neuberger Berman Group LLC | ADD | 558,323 | 728,717 | +30.5% | $201.2M |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | ADD | 441,148 | 709,484 | +60.8% | $195.6M |
| BNP PARIBAS FINANCIAL MARKETS | DOUBLED | 332,651 | 674,778 | +102.8% | $186.0M |
| SEI INVESTMENTS CO | TRIM | 865,893 | 524,548 | -39.4% | $144.6M |
| PRUDENTIAL FINANCIAL INC | ADD | 324,266 | 512,254 | +58.0% | $141.2M |
Insider activity
Buying and selling by company executives and directors (SEC Form 4).
18 insiders, 50 transactions. Net -$66.8M — $0.00 bought, $66.8M sold.
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Sep 3, 2026 | Neville Everett | See Remarks | SELL | 617 | $284.05 | $175.3K |
| Sep 1, 2026 | Evanko Brian C | See Remarks | AWARD | 6,716 | — | — |
| Sep 1, 2026 | Evanko Brian C | See Remarks | AWARD | 3,113 | — | — |
| Aug 31, 2026 | Kurian George | Director | AWARD | 108.664 | $276.08 | $30.0K |
| Aug 18, 2026 | Jones Nicole S | See Remarks | SELL | 2,677 | $279.61 | $748.5K |
| Aug 6, 2026 | Holgerson Bryan | See Remarks | AWARD | 0.984 | $275.25 | $270.76 |
| Aug 5, 2026 | Jones Nicole S | See Remarks | EXERCISE | 1,301 | $192.02 | $249.8K |
| Aug 4, 2026 | Jones Nicole S | See Remarks | EXERCISE | 14,045 | $192.02 | $2.7M |
| Aug 4, 2026 | Jones Nicole S | See Remarks | SELL | 19,436 | $276.27 | $5.4M |
| Jul 23, 2026 | Holgerson Bryan | See Remarks | AWARD | 0.946 | $286.29 | $270.77 |
Congressional trades
CI trades disclosed by members of Congress, with disclosure delay.
3 members · 2 buys / 3 sells
| Date | Member | Party | Chamber | Type | Amount | Asset | Disclosed |
|---|---|---|---|---|---|---|---|
| Mar 27, 2026 | Alan Armstrong | R | SENATE | BUY | $1,001 - $15,000 | Cigna Corp | Jul 22, 2026(117d) |
| Mar 23, 2026 | Jared Moskowitz | D | HOUSE | SELL | $1,001 - $15,000 | Cigna Corp | May 1, 2026(40d) |
| Mar 23, 2026 | Jared Moskowitz | D | HOUSE | SELL | $1,001 - $15,000 | Cigna Corp | May 1, 2026(40d) |
| Sep 23, 2025 | Julie Johnson | D | HOUSE | BUY | $1,001 - $15,000 | Cigna Corp | Aug 6, 2026(318d) |
| Sep 23, 2025 | Julie Johnson | D | HOUSE | SELL | $1,001 - $15,000 | Cigna Corp | Aug 6, 2026(318d) |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for CI.
Shares short
6,562,998
Settlement Sep 15, 2026
Change vs prior
+4.6%
Semi-monthly cycle
Days to cover
4.6
At avg daily volume
Of shares outstanding
≈2.5%
Estimate — not % of float
All CI filing & press-release reports (10)
- 144 reportSep 3, 2026
- 144 reportAug 18, 2026
- 144 reportAug 4, 2026
- 3 reportJul 10, 2026
- COURT-RULING reportJul 3, 2026
- 8-K reportMay 13, 2026
- 8-K reportApr 30, 2026
- COURT-RULING reportApr 24, 2026
- DEFA14A reportMar 13, 2026
- 8-K reportFeb 27, 2026